Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammed Murtaza

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos One|July 22, 2022
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patientsShukmei Wong, E J Ehrhart, Samuel Stewart, et al.
JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
Scientific Reports|May 11, 2018
Evaluation of pre-analytical factors affecting plasma DNA analysisHavell Markus, Tania Contente-Cuomo, Maria Farooq, et al.
The New England Journal of Medicine|March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancerSarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
Plos One|September 18, 2014
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesCorine M Beaufort, Jean C A Helmijr, Anna M Piskorz, et al.
Annals of Surgical Oncology|October 2, 2023
Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal AdenocarcinomaClayton T Marcinak, Corinne E Praska, Roberto J Vidri, et al.
Plos Medicine|February 25, 2015
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysisRoland F Schwarz, Charlotte K Y Ng, Susanna L Cooke, et al.
Nature|April 9, 2013
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAMuhammed Murtaza, Sarah-Jane Dawson, Dana W Y Tsui, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos One|July 22, 2022
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patientsShukmei Wong, E J Ehrhart, Samuel Stewart, et al.
JCO Precision Oncology|April 7, 2023
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell CarcinomaAlexander Chehrazi-Raffle, Ramya Muddasani, Nazli Dizman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2025
Virus-free CRISPR knockin of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cellsKeerthana Shankar, Isabelle Zingler-Hoslet, Diana M Tabima, et al.
Scientific Reports|May 11, 2018
Evaluation of pre-analytical factors affecting plasma DNA analysisHavell Markus, Tania Contente-Cuomo, Maria Farooq, et al.
The New England Journal of Medicine|March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancerSarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
Plos One|September 18, 2014
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesCorine M Beaufort, Jean C A Helmijr, Anna M Piskorz, et al.
Annals of Surgical Oncology|October 2, 2023
Association of Neighborhood Disadvantage with Short- and Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal AdenocarcinomaClayton T Marcinak, Corinne E Praska, Roberto J Vidri, et al.
Plos Medicine|February 25, 2015
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysisRoland F Schwarz, Charlotte K Y Ng, Susanna L Cooke, et al.
Nature|April 9, 2013
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNAMuhammed Murtaza, Sarah-Jane Dawson, Dana W Y Tsui, et al.
Pageof 5